Neomycin/Polymyxin B/Hydrocortisone/Bacitracin

DEA Class; Rx

Common Brand Names; Neo-Polycin HC

  • Corticosteroids, Ophthalmic

Bacitracin/hydrocortisone/neomycin/polymyxin topical (OTC)

Brand and Other Names: Cortisporin Ointment
  • Classes: Corticosteroids, Topical; 
  • Topical Antimicrobials

Topical combination product containing steroid and antibacterial/antifungal agent
Used for the treatment of skin infections

Indicated for the treatment of corticosteroid-responsive inflammatory ocular conditions where a bacterial ophthalmic infection or a risk of bacterial ophthalmic infection exists (e.g., inflammation of palpebral and bulbar conjunctiva, cornea and anterior segment of the globe where the inherent risk of corticosteroid use in bacterial conjunctivitis is accepted to obtain a decrease in edema and inflammation; also in chronic anterior uveitis and corneal injury from chemical, radiation, or thermal burns, or penetration of foreign objects).

For the treatment of corticosteroid-responsive dermatoses with secondary infection.

Hypersensivity to neomycin

Glaucoma

Viral diseases of cornea and conjunctiva (epithelial herpes simplex keratitis, vaccinia, varicella)

Mycobacterial infection of eye & fungal diseases of ocular structures

Hypersensitivity

  • Allergies
  • Glaucoma
  • Rash
  • Superinfection (herpes)
  • Skin sensitization
  • Burning
  • Itching
  • Irritation
  • Dryness
  • Folliculitis
  • Hypertrichosis
  • Acneiform eruptions
  • Hypopigmentation
  • Perioral dermatitis
  • Allergic contact dermatitis
  • Maceration of the skin
  • Secondary infection
  • Skin atrophy
  • Striae
  • Miliaria

Not used much, because of hypersensitivity reactions to neomycin; also, because of steroid component, adequate follow up is essential

Prolonged use or misuse of ocular corticosteroid may result in glaucoma, superinfection (herpes) etc

Newer agents have better steroid & antibiotic coverage

For external use only

Pregnancy Category: C

Lacation: Unknown

Adults

8 g or 10 days for ophthalmic ointment then reevaluate before further therapy; 4 applications/day for up to 7 days topically.

Elderly

8 g or 10 days for ophthalmic ointment then reevaluate before further therapy; 4 applications/day for up to 7 days topically.

Adolescents

Safety and efficacy have not been established.

Children

Safety and efficacy have not been established.

Infants

Safety and efficacy have not been established.

Bacitracin ophthalmic/neomycin/polymyxin B/hydrocortisone

ophthalmic ointment

  • 400units/0.35%/10,000units/1%

Bacitracin/hydrocortisone/neomycin/polymyxin

topical ointment

  • (400 units/10mg/35mg/4000 units)/1gram

About the Author

You may also like these

0